Targeted treatment options for the management of metastatic/persistent and recurrent cervical cancer
Author:
Affiliation:
1. Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, Smilow Cancer Hospital, Yale University, School of Medicine, New Haven, CT, USA
Funder
This paper received no funding
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2022.2075348
Reference67 articles.
1. A study of pembrolizumab on the tumoral immunoprofile of gynecologic cancers [2021 October 14]. Available from: https://clinicaltrials.gov/ct2/show/NCT02728830
2. Society AC. Key Statistics for Cervical Cancer [December 26 2021]. Available from: https://www.cancer.org/cancer/cervical-cancer/about/key-statistics.html#:~:text=The%20American%20Cancer%20Society’s%20estimates,will%20die%20from%20cervical%20cancer
3. Ries LAG HD, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003 [2021 December 26]. Available from: https://seer.cancer.gov/archive/csr/1975_2003/
4. Prognostic Factors and Relapse Patterns in Early-Stage Cervical Carcinoma after Brachytherapy and Radical Hysterectomy
5. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update for a nonrandomized comparison
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway;European Journal of Medical Research;2024-07-05
2. Progress in the study of antibody-drug conjugates for the treatment of cervical cancer;Frontiers in Oncology;2024-06-06
3. Synergic Chemoimmunotherapy of Cervical Cancer by Combining Cisplatin with Thermosensitive Polypeptide Fused Interferon Alpha;Advanced Therapeutics;2024-06-05
4. Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix;International Journal of Molecular Sciences;2024-06-05
5. Extracellular cancer‑associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor‑promoting roles and prognosis biomarker functions;Oncology Letters;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3